Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.

MLA

Cocco, E., et al. “Serum Amyloid A (SAA): A Novel Biomarker for Uterine Serous Papillary Cancer.” British Journal of Cancer, vol. 101, no. 2, July 2009, pp. 335–41. EBSCOhost, https://doi.org/10.1038/sj.bjc.6605129.

APA

Cocco, E., Bellone, S., El-Sahwi, K., Cargnelutti, M., Casagrande, F., Buza, N., Tavassoli, F. A., Siegel, E. R., Visintin, I., Ratner, E., Silasi, D.-A., Azodi, M., Schwartz, P. E., Rutherford, T. J., Pecorelli, S., & Santin, A. D. (2009). Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. British Journal of Cancer, 101(2), 335–341. https://doi.org/10.1038/sj.bjc.6605129

Chicago

Cocco, E., S. Bellone, K. El-Sahwi, M. Cargnelutti, F. Casagrande, N. Buza, F. A. Tavassoli, et al. 2009. “Serum Amyloid A (SAA): A Novel Biomarker for Uterine Serous Papillary Cancer.” British Journal of Cancer 101 (2): 335–41. doi:10.1038/sj.bjc.6605129.